Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.
Benzinga · 09/29/2022 09:09
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/28/2022 18:43
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 09/28/2022 16:40
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 09/19/2022 18:25
LIFE, TBLT and XTLB among pre market gainers
Super Micro Computer (SMCI) +20% <a href="
Seekingalpha · 07/21/2022 12:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 05/17/2022 12:09
G Medical, ChemoCentryx top healthcare gainers; Denali, Immix among losers
Gainers: G Medical Innovations (NASDAQ:GMVD) +20%. ChemoCentryx (NASDAQ:CCXI) +12%. Homology Medicines (NASDAQ:FIXX) +8%. Babylon Holdings (NYSE:BBLN) +7%. XTL Biopharmaceuticals (NASDAQ:XTLB) +7%. Losers: Denali Therapeutics Inc. (NASDAQ:DNLI) -13%. Immix...
Seekingalpha · 01/13/2022 15:02
Triple-S Management, Bio-Path leads healthcare gainers; Theravance Biopharma, Vivos Therapeutics among major losers
Gainers: Triple-S Management (NYSE:GTS) +45%, Bio-Path (NASDAQ:BPTH) +21%, Reviva Pharmaceuticals (NASDAQ:RVPH) +21%, XTL Biopharmaceuticals (NASDAQ:XTLB) +13%, Protara Therapeutics (NASDAQ:TARA) +12%. Losers: Theravance Biopharma (NASDAQ:TBPH) -31%, Vivos...
Seekingalpha · 08/24/2021 15:10
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
Benzinga · 08/24/2021 09:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/23/2021 12:12
25 Stocks Moving in Monday's Pre-Market Session
Benzinga · 08/23/2021 11:00
58 Biggest Movers From Friday
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.
Benzinga · 08/23/2021 09:06
ONVO, JOBY and PXLW among mid-day movers
Gainers: Greenpro Capital (NASDAQ:GRNQ) +61%. GeoVax Labs (NASDAQ:GOVX) +49%. Flora Growth Corp. (NASDAQ:FLGC) +31%. Pixelworks (NASDAQ:PXLW) +20%. XTL Biopharmaceuticals (NASDAQ:XTLB) +18%. Leju Holdings (NYSE:LEJU) +17%. Zhihu (NYSE:ZH) +17%. Organovo (N...
Seekingalpha · 08/20/2021 16:34
GeoVax Labs, Flora Growth leads healthcare gainers; Progenity, Sonnet BioTherapeutics among major losers
Gainers: GeoVax Labs (NASDAQ:GOVX) +52%, Flora Growth (NASDAQ:FLGC) +30%, XTL Biopharmaceuticals (NASDAQ:XTLB) +17%, Organovo (NASDAQ:ONVO) +16%, Impel NeuroPharma (NASDAQ:IMPL) +11%. Losers: Progenity (NASDAQ:PROG) -55%, Sonnet BioTherapeutics (NASDAQ:SON...
Seekingalpha · 08/20/2021 15:04
74 Biggest Movers From Yesterday
Benzinga · 07/27/2021 09:14
75 Biggest Movers From Friday
Gainers The New Home Company Inc. (NYSE: NWHM) jumped 82.9% to settle at $8.89 on Friday after the company agreed to be acquired by funds managed by affiliates of Apollo Global Management for $9 per share in all-cash transaction.
Benzinga · 07/26/2021 09:14
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 07/23/2021 20:50
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 06/18/2021 12:19
11 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 05/18/2021 12:07
Second Sight Medical Products, OpGen leads healthcare gainers; Soleno Therapeutics, AnaptysBio among major losers
Gainers: Second Sight Medical Products (EYES) +92%, OpGen OPGN +79%, Anchiano Therapeutics (ANCN) +64%, Jaguar Health (JAGX) +29%, Idera Pharmaceuticals (IDRA) +22%.Losers: Soleno Therapeutics SLNO -44%, AnaptysBio ANAB -34%, Talis Biomedical TLIS -12%, Ru...
Seekingalpha · 03/08/2021 16:03
Webull provides a variety of real-time XTLB stock news. You can receive the latest news about Xtl Biopharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About XTLB
XTL Biopharmaceuticals Ltd is a biopharmaceutical company engaged in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren’s syndrome (SS). hCDR1 is a peptide (short protein) that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong the survival of patients for the treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by the kidney. EPO stimulates erythropoiesis, the production of red blood cells, by binding to its receptor on the surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.